Prism MarketView

January 17, 2024 at 9:26 am

Lexaria to Undertake Extensive GLP-1 Study Program to Support Commercial Discussions

Lexaria Bioscience (Nasdaq: LEXX) has announced it will initiate an extensive glucagon-like peptide-1 (GLP-1) study program in 2024 to support prospective commercial partnering with the… [Read More]

January 16, 2024 at 4:03 pm

Vaxart Announces $10.0 Million Registered Direct Offering; Shares Climb 30%

Vaxart, Inc. (Nasdaq: VXRT) announced today that it had entered into a common stock purchase agreement with RA Capital Management for the sale of 15,384,615… [Read More]

January 16, 2024 at 2:23 pm

Biotech Breakfast – Healthcare Equities Lower; GSK, Pfizer Gain and Moderna Slides as RSV Vaccine Trends in Sharp Focus

Friday was an uneventful day for healthcare equities which finished the session lower overall, with Healthcare down (0.29%) versus the S&P 500 which gained +0.08%…. [Read More]

January 12, 2024 at 10:44 am

Spectral AI Initiates Pivotal Study Evaluating DeepView AI® for Burn Injuries

Medical diagnostics AI company Spectral AI, Inc. (Nasdaq: MDAI) has enrolled the first patient in a pivotal study to validate DeepView AI® using its proprietary… [Read More]

January 12, 2024 at 9:30 am

Nexalin Technology HALO™ Clarity Device Offers Hope for Treating Mental Health Conditions

Nexalin Technology, Inc. (Nasdaq: NXL) has launched its Gen-3 HALO™ Clarity neurostimulation device designed to treat mental health conditions including Major Depressive Disorder (MDD), addiction… [Read More]

January 09, 2024 at 3:30 pm

PRISM MarketView Honors National Biotechnology Month with a Spotlight on Emerging Biotech Innovators

In celebration of National Biotechnology Month, PRISM MarketView acknowledges the significant advancements in biotechnology since its establishment by President Clinton in 2000. This month-long celebration… [Read More]

January 08, 2024 at 4:49 pm

Novartis and Lilly Collaborate with Alphabet for AI Drug Discovery

Novartis Pharma (NYSE: NVS) and Eli Lilly and Co (NYSE: LLY) have entered into strategic research collaborations with Isomorphic Labs, a unit of Alphabet (Nasdaq:… [Read More]

January 08, 2024 at 4:46 pm

M&A Madness: Novartis Continues Buying Spree

Novartis (NYSE: NVS) remains at the center of January’s flurry of M&A activity after entering three different agreements on Monday. The Wall Street Journal also… [Read More]

January 08, 2024 at 10:09 am

Merck Scoops Harpoon in $680M Deal

Harpoon Therapeutics, Inc. (Nasdaq: HARP) has agreed to be acquired by Merck (NYSE: MRK) in a cash deal valued at approximately $680 million. Harpoon’s share… [Read More]

January 05, 2024 at 10:51 am

GeoVax Completes Patient Enrollment in Head and Neck Cancer Trial

Clinical-stage biotechnology company, GeoVax Labs, Inc. (Nasdaq: GOVX), has completed patient enrollment for its Phase 1/2 clinical study evaluating Gedeptin® in patients suffering from advanced… [Read More]

January 04, 2024 at 3:02 pm

Omega Therapeutics Surges 107% on Novo Nordisk Obesity R&D Partnership

Shares in Omega Therapeutics, Inc. (Nasdaq: OMGA) have surged today following news that the company has entered a research partnership with Novo Nordisk ($NVO) to… [Read More]

January 04, 2024 at 12:48 pm

Lexaria Oral Delivery Technology Outperforms GLP-1 Drug, Rybelsus®

Lexaria Bioscience (Nasdaq: LEXX) has reported positive final results from a pilot study evaluating its DehydraTECHTM technology for the oral delivery of the GLP-1 drug… [Read More]

Tag: BIO TECH